SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-048073
Filing Date
2017-09-14
Accepted
2017-09-14 17:00:25
Documents
3
Period of Report
2017-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v475191_8k.htm 8-K 26689
2 EXHIBIT 10.1 v475191_ex10-1.htm EX-10.1 38684
3 GRAPHIC image_001.jpg GRAPHIC 2075
  Complete submission text file 0001144204-17-048073.txt   69721
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 171086158
SIC: 1000 Metal Mining
Assistant Director 9